News
DaVita’s second quarter was met with a significant negative market reaction, as shares declined sharply despite management ...
DaVita has underperformed the broader market over the past year, and analysts are cautious about the stock’s prospects.
DaVita fell victim to a cyberattack back in March of this year during which time hackers gained unauthorized access to its ...
US healthcare company DaVit has revealed it suffered a ransomware attack and a data breach earlier this year which saw ...
DaVita has notified over 1 million individuals that their personal and health information was stolen in a ransomware attack.
View the latest DaVita Inc. (DVA) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Shares of DaVita Inc. DVA advanced 1.42% to $129.50 Friday, on what proved to be an all-around great trading session for the ...
DaVita and medical device company Medtronic launched their new venture, Mozarc Medical, to develop new kidney care technologies with a specific focus on at-home treatments. Announced nearly a year ...
DaVita on Feb. 1 announced the federal government will pay the company $538 million to settle claims the U.S. Department of Veterans Affairs underpaid it for services performed between 2005 and 2011.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results